Dr. Srividya Chandramouli is a patent agent in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s patents and innovations practice. Her background includes in-depth research experience in single-cell genomic and proteomic analysis, synthetic biology, neuroscience, small-molecule target validation and screening, and a Master’s degree in engineering technology. Srividya focuses on patent prosecution and due diligence matters for clients in the life sciences, biotechnology, medical device, diagnostics, pharmaceutical, and health technology industries.

Prior to joining the firm, Srividya was the handling editor for Trends in Biochemical Sciences at Cell Press, where she oversaw the strategic editorial vision and implementation of the publication process for a research portfolio spanning diverse interdisciplinary approaches to biochemical sciences. She is a MIT Kaufman Instructor and served as a strategic consultant with the Research without Borders Program for capacity building and promotion of surgical research and communication in Africa. She is currently an advisor for the MIT Sandbox Program to enable student-led entrepreneurship ideas.

As a postdoctoral fellow with professor Susan Lindquist at Whitehead Institute at MIT, Srividya worked on an interdisciplinary approach combining computational and experimental methods for development of allosteric small molecule modulators of the E3 ligase Rsp5/Nedd4 to reverse a-synuclein toxicity in yeast and human neuronal models of Parkinson’s disease. During her doctoral studies, she focused on the molecular mechanisms regulating neuronal dendrite development.